Old Web
English
Sign In
Acemap
>
authorDetail
>
Von Potter
Von Potter
Yale University
Medicine
Immunology
Oncology
Internal medicine
Cetuximab
4
Papers
37
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Trial in Progress: A Phase 2, Open-Label Study Evaluating the Safety and Efficacy of the PKR Activator Etavopivat (FT-4202) in Patients with Thalassemia or Sickle Cell Disease
2021
Blood
Ashutosh Lal
R. Clark Brown
Thomas D. Coates
Theodosia A. Kalfa
Janet L. Kwiatkowski
Julie Brevard
Von Potter
Ken Wood
Sujit Sheth
Show All
Source
Cite
Save
Citations (0)
A Phase 1 Trial of Vorinostat and Pegylated Liposomal Doxorubicin In Relapsed or Refractory Lymphoma.
2010
Blood
Frederick Lansigan
Stuart Seropian
Dennis L. Cooper
Von Potter
Noelle Sowers
Francine M. Foss
Show All
Source
Cite
Save
Citations (1)
Successful re-challenge with panitumumab in patients who developed hypersensitivity reactions to cetuximab: report of three cases and review of literature
2009
Cancer Chemotherapy and Pharmacology
Muhammad Wasif Saif
Jennifer Peccerillo
Von Potter
Show All
Source
Cite
Save
Citations (36)
Successful re-challenge with panitumumab (PAN) in patients (pts) with GI cancers who developed hypersensitivity reactions (HSR) to cetuximab (CET)
2008
Journal of Clinical Oncology
Von Potter
M.J. Davies
Jennifer Peccerillo
Muhammad Wasif Saif
Show All
Source
Cite
Save
Citations (0)
1